Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.
about
De novo protein sequence analysis of Macaca mulattaAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsBrain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic ReviewEffects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalizationChronic treatment with aripiprazole induces differential gene expression in the rat frontal cortexSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceParametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapinecAMP response element binding protein phosphorylation in nucleus accumbens underlies sustained recovery of sensorimotor gating following repeated D₂-like receptor agonist treatment in ratsTime-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy: An exploratory study.Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.Classics in Chemical Neuroscience: Aripiprazole.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.Acute administration of clozapine and risperidone altered dopamine metabolism more in rat caudate than in nucleus accumbens: a dose-response relationshipPlastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Shape abnormalities of caudate nucleus in schizotypal personality disorder.Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.Time-lapse mapping of cortical changes in schizophrenia with different treatmentsRecovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugsThe transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium.The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice.The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment.Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.Subcortical neuromorphometry in schizophrenia spectrum and bipolar disorders.Patterns of spontaneous magnetoencephalographic activity in patients with schizophrenia.Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging.Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia.Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia.Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder.Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?The role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders.A Case Study on Promoting Neuroplasticity in a Patient With Schizophrenia.
P2860
Q24670134-8D5B8200-66AA-45E8-8C01-E08D51E9136BQ26745506-363C8349-D95A-416D-A44D-0246F98524BEQ26786253-41DFD179-4E1D-48BE-B1BB-302B7428613FQ28535151-3029875C-877D-48CB-88C4-46C2AF6A5003Q28577651-61311595-60CD-471B-863B-DFB187A04B2BQ29618819-68A85616-0828-4BFE-9631-F4BA3FA23086Q30390855-6ACFE2E6-E5B0-4D0F-8D20-6B37DEE651E4Q30428091-50AA9F8B-EB02-4DE4-B8ED-519322745ACFQ30428213-6CDDF734-17A8-42BB-B8F1-7071A90C2279Q30458533-7715DD04-681A-4366-91F0-CDEAA78091C0Q30470838-4495479C-B91C-4D17-A4A5-3CB3DA4DB713Q30981438-BB1BB25D-0DAE-490D-9D2A-BA6D644CE399Q33590599-E6D910FA-431D-4182-9B69-8707E908EFF2Q33846961-F5B6F048-18CA-4F67-8158-3CD377080DA3Q33866125-1E2C59F4-70B5-48CB-90ED-416CB2071210Q34274859-929ED64A-F57C-4F13-8198-F743CAB2F64AQ34372135-DD86713A-95A0-47B0-8D3C-B2F4CB9BFA17Q34409947-C3D8AE0E-7435-43E6-B309-864EBDBCADCDQ34557613-435D2CDF-CC31-4CBF-87B7-BB95320B6967Q34605931-EF845498-44CE-4B5D-B6AB-366B9AC54D0BQ34980328-BF83375E-AC40-429B-A103-E59C19EB573DQ35015837-7C0BDD92-1E97-497D-BA78-9EEB1463EEB9Q35087719-5270D013-0E28-4540-86A0-C342654D9BC7Q35451948-4B2EB8B1-2172-4326-B26D-847AFD702C4FQ35881717-16FF1B96-233F-46D4-8644-E021906B8651Q36325448-2B6E51B1-736E-4CB0-9E25-29679B31CE37Q36390750-CF351909-8FAB-421D-90C3-65F7181E2B2AQ36590407-9DEDF8A1-263B-4C0A-B6E0-6AB49C77B4E8Q36661326-C12B0F0C-81A3-4AE7-8240-8AA7E4B2464BQ36881922-BF0088F4-697D-45FA-8B5A-CCA42FC3FA8CQ36939248-14AAF1C7-14BA-46F6-B693-3097892EFAEAQ37306496-87FBE37C-5B8C-4F32-841F-EFA5D3BCF2CAQ37338151-834A48BB-C301-4694-A826-333A848A19E1Q37419760-26FC4D75-25E8-4836-8220-1F83B4BCE086Q37475495-84F20120-EF36-49BC-8105-58883CFFFDBAQ37627386-BB1B7C66-2EE4-4D6F-B471-8C8985D905C5Q37676119-ABD7F486-C26B-43CA-B421-80B8790D5094Q37783637-C6351B4B-7952-4DFC-B10D-87C0B0DD276CQ37880098-32D95ADF-2795-4F48-BB5D-C254696DF173Q38364849-CCB9D24E-2E95-4414-A66D-8084EB1021C8
P2860
Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@ast
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@en
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@nl
type
label
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@ast
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@en
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@nl
prefLabel
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@ast
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@en
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@nl
P2860
P1476
Antipsychotic drugs and neurop ...... neurobiology of schizophrenia.
@en
P2093
P2860
P304
P356
10.1016/S0006-3223(01)01267-7
P407
P577
2001-11-01T00:00:00Z